Loading...
Medifast, Inc.
MED•NYSE
Consumer CyclicalPersonal Products & Services
$12.68
$0.21(1.68%)
Medifast, Inc. (MED) Financial Performance & Statements
Review Medifast, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-43.80%
↓ 43.80%
Operating Income Growth
-97.72%
↓ 97.72%
Net Income Growth
-97.90%
↓ 97.90%
Operating Cash Flow Growth
-83.42%
↓ 83.42%
Operating Margin
-1.16%
↓ 1.16%
Gross Margin
73.89%
↑ 73.89%
Net Profit Margin
-1.29%
↓ 1.29%
ROE
-3.36%
↓ 3.36%
ROIC
-2.88%
↓ 2.88%
Medifast, Inc. (MED) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Medifast, Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $115.73M | $119.003M | $140.16M | $168.56M |
| Cost of Revenue | $31.48M | $30.78M | $34.49M | $45.12M |
| Gross Profit | $84.25M | $88.22M | $105.67M | $123.44M |
| Gross Profit Ratio | $0.73 | $0.74 | $0.75 | $0.73 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $1.10M |
| SG&A Expenses | $85.51M | $87.51M | $103.57M | $130.21M |
| Operating Expenses | $85.51M | $87.51M | $103.57M | $131.31M |
| Total Costs & Expenses | $116.99M | $118.29M | $138.06M | $176.43M |
| Interest Income | $1.30M | $953000.00 | $1.33M | $1.30M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $3.19M | $3.19M | $3.07M |
| EBITDA | -$1.26M | $3.89M | $5.30M | -$4.81M |
| EBITDA Ratio | -$0.01 | $0.03 | $0.04 | -$0.03 |
| Operating Income | -$1.26M | $709000.00 | $2.11M | -$7.88M |
| Operating Income Ratio | -$0.01 | $0.006 | $0.02 | -$0.05 |
| Other Income/Expenses (Net) | $1.79M | $566000.00 | -$528000.00 | -$2.77M |
| Income Before Tax | $526000.00 | $1.27M | $1.58M | -$10.65M |
| Income Before Tax Ratio | $0.005 | $0.01 | $0.01 | -$0.06 |
| Income Tax Expense | $1.30M | $474000.00 | $449000.00 | -$2.50M |
| Net Income | -$772000.00 | $800000.00 | $1.13M | -$8.15M |
| Net Income Ratio | -$0.007 | $0.007 | $0.008 | -$0.05 |
| EPS | -$0.07 | $0.07 | $0.10 | -$0.75 |
| Diluted EPS | -$0.07 | $0.07 | $0.10 | -$0.75 |
| Weighted Avg Shares Outstanding | $10.95M | $10.93M | $10.94M | $10.94M |
| Weighted Avg Shares Outstanding (Diluted) | $10.95M | $10.96M | $10.97M | $10.94M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan